The use of different formulations of tocilizumab in the treatment of patients with moderate to severe COVID-19

The use of different formulations of tocilizumab in the treatment of patients with moderate to severe COVID-19

The objective of the study: to compare changes in the blood level of C-reactive protein (CRP) during the administration of different formulations of tocilizumab (TCZ) in COVID-19 patients admitted to hospital in real clinical practice.Subjects and methods. The cohort of 14 patients was included in t...

Full description

Saved in:
Bibliographic Details
Main Authors: E. I. Veselova, G. D. Kaminskiy, O. V. Lovacheva, B. A. Nanaeva, R. I. Romanov, А. V. Veselov
Format: Article
Language:Russian
Published: New Terra Publishing House 2021-02-01
Series:Туберкулез и болезни лёгких
Subjects:
covid-19
tocilizumab for subcutaneous and intravenous administration
changes in c-reactive protein levels
Online Access:https://www.tibl-journal.com/jour/article/view/1497
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tibl-journal.com/jour/article/view/1497

Similar Items